![]() |
市场调查报告书
商品编码
1661102
2025 年至 2033 年生物保存市场报告,按产品类型(生物保存设备、生物保存介质)、应用(治疗应用、生物库应用、药物发现应用)和地区划分Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033 |
2024IMARC Group全球生物保存市场规模达到 85 亿美元。大众对个人化医疗的日益关注、对研发活动的投资不断增加以及对罕见疾病的认识和理解不断提高是推动市场发展的主要因素。
生物保存是指将生物材料(如细胞、组织、器官或整个生物体)在存活和功能状态下长期保存的过程。该过程的目标是保持生物材料的完整性、活力和功能性,使其能够储存、运输和用于各种目的,包括研究、临床应用和工业过程。它在各个领域都有广泛的应用,包括医学、生物技术和用于储存细胞、组织和器官以供移植、再生医学和药物开发的研究。
全球市场的主要驱动力是大众对个人化医疗的日益关注。此外,政府、学术机构和私人组织在生命科学、生物技术和医疗保健领域的研发活动不断增加的投资,为市场的发展提供了推动力。此外,随着人们对罕见疾病和遗传性疾病的认识和理解不断提高,保存受影响人群的生物样本的需求也日益增加。这些技术支援这些样本的收集和储存,以研究疾病机制、开发诊断方法并促进标靶治疗的发展,从而满足全球需求。此外,改进的冷冻保护剂、自动化系统和增强的储存协议的发展正在扩大生物保存的能力和应用,因为它们有助于保持保存的生物材料的效率、可靠性和安全性,进一步创造了积极的市场前景。
生物银行需求不断成长
生物银行需求的不断增长对全球市场产生了重大影响。生物库是储存各种生物样本(包括细胞、组织、血液、DNA 和其他生物材料)以用于研究和诊断目的的储存库。这些技术对于维护这些样本的完整性、活力和功能性,确保其长期储存和可用性发挥着至关重要的作用。大规模人群研究、临床试验和研究计画需要多样化且保存完好的生物样本,而这些需求的日益增长正在影响全球生物库领域。此外,人们对精准医疗和个人化医疗的日益关注也放大了生物库的重要性,因为它们提供了可用于基因组测试、生物标记发现和客製化治疗开发的全面样本。
再生医学的持续进步
再生医学的进步对全球市场产生了重大影响。生物保存透过保存细胞、组织和工程结构的活力和功能,在再生医学的成功中起着至关重要的作用,因为再生医学的目的是利用基于细胞的疗法、组织工程和其他创新方法来修復或替换受损的组织或器官。此外,这些技术对于在储存和运输过程中维持干细胞的活力和效力至关重要。冷冻和玻璃化等冷冻保存方法通常用于保存干细胞以供将来用于治疗或研究。干细胞保存规则和冷冻保护剂的进步提高了干细胞的活力和解冻后功能,促进了市场的成长。
生物製药产业的扩张
生物製药产业的扩张是影响市场的重要因素。生物製药产业专注于生物药物的开发和生产,包括治疗性蛋白质、抗体、疫苗和基于细胞的疗法。生物保存对于确保这些复杂生物产品从开发到分销的整个生命週期的稳定性、品质和完整性起着至关重要的作用。由于生物药物对温度、光照和湿度等环境条件高度敏感,因此对这些技术的需求大幅增加,因为它们对于在储存和运输过程中保持这些药物的稳定性和品质至关重要。透过采用冷冻保存、冷冻干燥或其他适当的保存方法,生物製药公司可以延长其产品的保质期,并确保其给患者使用时的有效性和安全性。
The global biopreservation market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.98% during 2025-2033. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.
Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.
The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.
Increasing Demand for Biobanking
The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.
Continual Advancements in Regenerative Medicine
Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.
The Expansion of the Biopharmaceutical Industry
The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.
Biopreservation equipment dominates the market
Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.
On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.
Biobank applications hold the largest share in the market
Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.
On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.
Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.
On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.
Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.